The Immunology Podcast cover image

Ep. 76: “Innate-Like T Lymphocytes” Featuring Dr. Mitchell Kronenberg

The Immunology Podcast

00:00

Targeting TRBC1 in T Cell Cancers with Antibody Drug Conjugates

Exploration of using antibody drug conjugates to target TRBC1 in T cell cancers, contrasting with genetically engineered T cells. The chapter highlights the importance of specific molecule targeting, challenges in creating lasting impact on cancer cells, and potential health risks of T cell activation. It also delves into the transmission and impact of the Congo hemorrhagic fever virus and a detailed study on viral entry mechanism involving glycoproteins and receptors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app